Migraine is more than just a headache—it’s a complex neurological disorder that affects millions worldwide. At PainConnect, Dr. Peter Goadsby will present his highly anticipated keynote session, “Bench to Bedside – New Understanding and Better Treatment for Migraine” on Friday, April 4^th at 8:00 am. A leading expert in headache research, Dr. Goadsby will unveil the latest breakthroughs in migraine science and how they are revolutionizing treatment.

What to Expect

This keynote session will bridge the gap between research and clinical practice, covering:

• The Neurobiology of Migraine: How our evolving understanding of brain mechanisms is changing the way we approach migraine care.
• Breakthrough Treatments: The latest in CGRP-targeted therapies and other cutting-edge interventions.
• Translating Science into Practice: How recent discoveries are shaping more effective, personalized treatment strategies for patients.

Why It Matters

Dr. Goadsby’s work has been instrumental in shifting migraine from a misunderstood condition to a well-defined neurological disorder with targeted therapies. His research has led to groundbreaking treatments that provide relief for those who once had limited options. This session will equip attendees with valuable insights into the future of migraine management, ensuring better patient outcomes.

Don’t miss the opportunity to hear from one of the foremost leaders in headache medicine. Join PainConnect and gain knowledge that will transform the way you approach migraine treatment.

Register today and be part of the future of migraine care!